Ignite Creation Date:
2024-05-05 @ 4:44 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00300950
Status:
COMPLETED
Last Update Posted:
2015-04-06
First Post:
2006-03-08
Brief Title:
Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic Post-resection Pancreas Cancer
Sponsor:
GlobeImmune
Organization:
GlobeImmune
Organization Data
Organization:
GlobeImmune
Class:
INDUSTRY
Study ID:
GI-4000-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GlobeImmune
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None